New medication for hot flashes in perimenopausal women
Part of Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study tests whether a new medication (CL25216) can help reduce hot flashes and other menopause symptoms in women going through perimenopause. It is specifically for overweight women who are still having irregular periods.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 40 and 55 years old who is overweight (BMI 25–29).
- You have noticed changes in your period for at least 3 months (irregular cycles, with more than 7 days difference in length).
- You still have your uterus and both ovaries.
- You have not used hormone therapy or any herbal products for menopause in the last 6 months.
- You have no history of blood clots, stroke, heart attack, or certain cancers, and you are not currently taking blood thinners.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if asimadoline can safely reduce hot flashes and night sweats in menopausal or late perimenopausal women. You must not be on any medications for hot flashes currently.
This study tests whether a new medication called CL25216 can reduce severe menstrual cramps and help balance hormones in women. If you experience moderate to severe period pain, this trial might help you find relief.
This study tests an oral product to see if it can help with menopause symptoms like hot flashes. It is for women aged 40–65 who still have a uterus and are not on hormone therapy.
This study tests a new treatment for women going through menopause who have frequent hot flashes. It aims to find a safe and effective way to reduce moderate to severe hot flashes.
This study looks at how hot flashes in midlife women might be connected to heart disease risk. Researchers want to see if managing hot flashes can improve heart health.
This trial tests a new approach to reduce hot flashes in women taking hormone therapy for breast cancer. You may be able to join if you have at least 14 hot flashes a week and are not taking certain other treatments.
Hear when a new Vasomotor Symptoms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.